TickerKhojComparison · NSE · data 2026-11-02
Aarti Drugs Limited vs Shukra Pharmaceuticals Ltd.
In plain words
Size: Aarti Drugs Limited is about 1.2 times the market value of Shukra Pharmaceuticals Ltd..
Valuation (P/E): Shukra Pharmaceuticals Ltd. 96.2 vs Aarti Drugs Limited 21.5.
Return on equity: Shukra Pharmaceuticals Ltd. 28.9% vs Aarti Drugs Limited 13.4%.
Profit growth over 3 years: Shukra Pharmaceuticals Ltd. 71% a year vs Aarti Drugs Limited 5.4% a year.
Debt to equity: Aarti Drugs Limited 0.37 vs Shukra Pharmaceuticals Ltd. 0.06.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AARTIDRUGS | SHUKRAPHAR | |
|---|---|---|
| Price | ₹449.45 | ₹74.54 |
| Market cap | ₹3,977 cr | ₹3,295 cr |
| P/E | 21.5 | 96.2 |
| P/B | — | — |
| ROE | 13.4% | 28.9% |
| ROCE | 13.2% | 31.3% |
| Debt / equity | 0.37 | 0.06 |
| Operating margin | 9.8% | 57.2% |
| Dividend yield | 0.46% | 0.01% |
| Sales growth, 3 years (yearly) | -2.0% | -1.2% |
| Profit growth, 3 years (yearly) | 5.4% | 71.0% |
| 1-year return | -10.4% | 77.3% |
| Revenue, last 12 months | ₹2,678 cr | ₹75 cr |
| Net profit, last 12 months | ₹191 cr | ₹34 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹50 cr | — |
| Quarter profit vs a year earlier | -6.9% | — |
| Promoter holding | 54.07% | 51.15% |
| Health check | Average (6/10) | Strong (6.6/10) |
Common questions
Which has a higher P/E, Aarti Drugs Limited or Shukra Pharmaceuticals Ltd.?
Shukra Pharmaceuticals Ltd. trades at the higher P/E (96.2 against 21.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Shukra Pharmaceuticals Ltd. (28.9% against 13.4%).
Which carries more debt?
Aarti Drugs Limited has the higher debt-to-equity ratio (0.37 against 0.06).